{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T19:25:02Z","timestamp":1782415502937,"version":"3.54.5"},"reference-count":47,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,10,6]],"date-time":"2022-10-06T00:00:00Z","timestamp":1665014400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81960710"],"award-info":[{"award-number":["81960710"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82060707"],"award-info":[{"award-number":["82060707"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82104381"],"award-info":[{"award-number":["82104381"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82174037"],"award-info":[{"award-number":["82174037"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2022,12]]},"DOI":"10.1016\/j.biopha.2022.113849","type":"journal-article","created":{"date-parts":[[2022,10,14]],"date-time":"2022-10-14T04:00:29Z","timestamp":1665720029000},"page":"113849","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"special_numbering":"C","title":["In vivo identification of the pharmacodynamic ingredients of Polygonum cuspidatum for remedying the mitochondria to alleviate metabolic dysfunction\u2013associated fatty liver disease"],"prefix":"10.1016","volume":"156","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3914-0003","authenticated-orcid":false,"given":"Li-Ping","family":"Yu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan-Qin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan-Juan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Zi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Xuan","family":"Tao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun-Jie","family":"Hao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xing-Xin","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.biopha.2022.113849_bib1","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.jhep.2020.03.039","article-title":"A new definition for metabolic dysfunction-associated fatty liver disease: an international expert consensus statement","volume":"73","author":"Eslam","year":"2020","journal-title":"J. Hepatol."},{"issue":"16","key":"10.1016\/j.biopha.2022.113849_bib2","doi-asserted-by":"crossref","DOI":"10.1002\/mnfr.201900043","article-title":"Mitochondria-mediated pathogenesis and therapeutics for non-alcoholic fatty liver disease","volume":"63","author":"Li","year":"2019","journal-title":"Mol. Nutr. Food Res."},{"issue":"18","key":"10.1016\/j.biopha.2022.113849_bib3","doi-asserted-by":"crossref","first-page":"3313","DOI":"10.1007\/s00018-018-2860-6","article-title":"Molecular mechanisms of hepatic lipid accumulation in non-alcoholic fatty liver disease","volume":"75","author":"Ipsen","year":"2018","journal-title":"Cell Mol. Life Sci."},{"issue":"1","key":"10.1016\/j.biopha.2022.113849_bib4","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1111\/jgh.13857","article-title":"Asia-Pacific Working Party on on-alcoholic fatty liver disease guidelines 2017-part 1: Definition, risk factors and assessment","volume":"33","author":"Wong","year":"2018","journal-title":"J. Gastroenterol. Hepatol."},{"issue":"6","key":"10.1016\/j.biopha.2022.113849_bib5","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1002\/hep.21655","article-title":"Inhibiting triglyceride synthesis improves hepatic steatosis but exacerbates liver damage and fibrosis in obese mice with nonalcoholic steatohepatitis","volume":"45","author":"Yamaguchi","year":"2007","journal-title":"Hepatology"},{"key":"10.1016\/j.biopha.2022.113849_bib6","doi-asserted-by":"crossref","DOI":"10.1016\/j.metabol.2021.154770","article-title":"Non-alcoholic fatty liver disease, insulin resistance, metabolic syndrome and their association with vascular risk","volume":"119","author":"Muzurovi\u0107","year":"2021","journal-title":"Metabolism"},{"issue":"1","key":"10.1016\/j.biopha.2022.113849_bib7","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1002\/hep.28431","article-title":"Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes","volume":"64","author":"Younossi","year":"2016","journal-title":"Hepatology"},{"issue":"6","key":"10.1016\/j.biopha.2022.113849_bib8","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1177\/1559827613488867","article-title":"Long-term adherence to health behavior change","volume":"7","author":"Middleton","year":"2013","journal-title":"Am. J. Lifestyle Med."},{"key":"10.1016\/j.biopha.2022.113849_bib9","doi-asserted-by":"crossref","DOI":"10.1016\/j.molmet.2020.101134","article-title":"Mitochondrial oxidative function in NAFLD: Friend or foe?","volume":"50","author":"Shum","year":"2021","journal-title":"Mol. Metab."},{"issue":"4","key":"10.1016\/j.biopha.2022.113849_bib10","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1038\/nrm3305","article-title":"A two-way street: reciprocal regulation of metabolism and signalling","volume":"13","author":"Wellen","year":"2012","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"6","key":"10.1016\/j.biopha.2022.113849_bib11","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.3390\/ijms21061905","article-title":"Natural products targeting ER stress, and the functional link to mitochondria","volume":"21","author":"Martucciello","year":"2020","journal-title":"Int J. Mol. Sci."},{"issue":"5","key":"10.1016\/j.biopha.2022.113849_bib12","doi-asserted-by":"crossref","first-page":"8713","DOI":"10.3390\/ijms15058713","article-title":"Role of mitochondria in nonalcoholic fatty liver disease","volume":"15","author":"Nassir","year":"2014","journal-title":"Int J. Mol. Sci."},{"issue":"6","key":"10.1016\/j.biopha.2022.113849_bib13","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1016\/j.jhep.2005.03.004","article-title":"NASH: a mitochondrial disease","volume":"42","author":"Pessayre","year":"2005","journal-title":"J. Hepatol."},{"issue":"3","key":"10.1016\/j.biopha.2022.113849_bib14","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1016\/j.jep.2013.05.007","article-title":"Botany, phytochemistry, pharmacology, and potential application of Polygonum cuspidatum Sieb.et Zucc.: a review","volume":"148","author":"Peng","year":"2013","journal-title":"J. Ethnopharmacol."},{"issue":"2","key":"10.1016\/j.biopha.2022.113849_bib15","first-page":"255","article-title":"Crude extract of Polygonum cuspidatum promotes immune responses in leukemic mice through enhancing phagocytosis of macrophage and natural killer cell activities in vivo","volume":"29","author":"Chueh","year":"2015","journal-title":"Vivo"},{"issue":"4","key":"10.1016\/j.biopha.2022.113849_bib16","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/j.jbiosc.2014.09.008","article-title":"Polygonum cuspidatum extracts as bioactive antioxidaion, anti-tyrosinase, immune stimulation and anticancer agents","volume":"119","author":"Lee","year":"2015","journal-title":"J. Biosci. Bioeng."},{"key":"10.1016\/j.biopha.2022.113849_bib17","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpba.2020.113839","article-title":"Anti-inflammatory constituents in the root and rhizome of Polygonum cuspidatum by UPLC-PDA-QTOF\/MS and lipopolysaccharide-activated RAW264.7 macrophages","volume":"195","author":"Yu","year":"2021","journal-title":"J. Pharm. Biomed. Anal."},{"issue":"2","key":"10.1016\/j.biopha.2022.113849_bib18","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0117602","article-title":"Polygonum cuspidatum and its active components inhibit replication of the influenza virus through toll-like receptor 9-induced interferon beta expression","volume":"10","author":"Lin","year":"2015","journal-title":"PLoS One"},{"issue":"5","key":"10.1016\/j.biopha.2022.113849_bib19","article-title":"Polydatin down-regulates the phosphorylation level of Creb and induces apoptosis in human breast cancer cell","volume":"12","author":"Chen","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.biopha.2022.113849_bib20","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2019.152986","article-title":"Polygonum cuspidatum extract attenuates fructose-induced liver lipid accumulation through inhibiting Keap1 and activating Nrf2 antioxidant pathway","volume":"63","author":"Zhao","year":"2019","journal-title":"Phytomedicine"},{"issue":"10","key":"10.1016\/j.biopha.2022.113849_bib21","first-page":"1971","article-title":"Study on material basis of Mahuang Fuzi Xixin decoction for anti-inflammation and immune suppression based on combined method of serum pharmacochemistry and serum pharmacology","volume":"40","author":"Tang","year":"2015","journal-title":"Zhongguo Zhong yao za zhi"},{"key":"10.1016\/j.biopha.2022.113849_bib22","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.chroma.2015.08.014","article-title":"Development of a mitochondria-based centrifugal ultrafiltration\/liquid chromatography\/mass spectrometry method for screening mitochondria-targeted bioactive constituents from complex matrixes: Herbal medicines as a case study","volume":"1413","author":"Yang","year":"2015","journal-title":"J. Chromatogr. A"},{"key":"10.1016\/j.biopha.2022.113849_bib23","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.jchromb.2019.04.005","article-title":"Comprehensive metabolism study of polydatin in rat plasma and urine using ultra-high performance liquid chromatography coupled with high-resolution mass spectrometry","volume":"1117","author":"Mei","year":"2019","journal-title":"J. Chromatogr. B Anal. Technol. Biomed. Life Sci."},{"issue":"6","key":"10.1016\/j.biopha.2022.113849_bib24","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.3390\/molecules24061058","article-title":"A study on tissue-specific metabolite variations in Polygonum cuspidatum by high-resolution mass spectrometry-based metabolic profiling","volume":"24","author":"Wu","year":"2019","journal-title":"Molecules"},{"issue":"5","key":"10.1016\/j.biopha.2022.113849_bib25","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1093\/chromsci\/bmy017","article-title":"Study on chemical constituents in Polygoni cuspidati folium and its preparation by UPLC-ESI-Q-TOF-MS\/MS","volume":"56","author":"Wang","year":"2018","journal-title":"J. Chromatogr. Sci."},{"key":"10.1016\/j.biopha.2022.113849_bib26","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.chroma.2013.02.058","article-title":"Pre-column incubation followed by fast liquid chromatography analysis for rapid screening of natural methylglyoxal scavengers directly from herbal medicines: case study of Polygonum cuspidatum","volume":"1286","author":"Tang","year":"2013","journal-title":"J. Chromatogr. A"},{"key":"10.1016\/j.biopha.2022.113849_bib27","article-title":"Discovery of pulmonary fibrosis inhibitor targeting TGF-\u03b2 RI in Polygonum cuspidatum by high resolution mass spectrometry with in silico strategy","author":"Xu","year":"2020","journal-title":"J. Pharm. Anal."},{"issue":"13","key":"10.1016\/j.biopha.2022.113849_bib28","first-page":"2796","article-title":"Studies on constituents of Polygonum multiflorum extract in vivo and in vitro based on UPLC-Q-TOF-MS","volume":"43","author":"Guo","year":"2018","journal-title":"Zhongguo Zhong Yao Za Zhi"},{"issue":"1","key":"10.1016\/j.biopha.2022.113849_bib29","first-page":"22","article-title":"An ulta-high-pressure liquid chromatography\/linear ion trap-Orbitrap mass spectrometry method coupled with a diagnostic fragment ions-searching- based strategy for rapid identification and characterization of chemical components in Polygonum cuspidatum","volume":"33","author":"Pan","year":"2015","journal-title":"Se Pu"},{"key":"10.1016\/j.biopha.2022.113849_bib30","doi-asserted-by":"crossref","first-page":"934","DOI":"10.3389\/fphar.2018.00934","article-title":"Integrating targeted and untargeted metabolomics to investigate the processing chemistry of polygoni multiflori radix","volume":"9","author":"Liang","year":"2018","journal-title":"Front Pharm."},{"issue":"1","key":"10.1016\/j.biopha.2022.113849_bib31","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/nrgastro.2017.109","article-title":"Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention","volume":"15","author":"Younossi","year":"2018","journal-title":"Nat. Rev. Gastroenter Hepatol."},{"issue":"6","key":"10.1016\/j.biopha.2022.113849_bib32","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1111\/j.1745-7254.2008.00807.x","article-title":"Resveratrol improves non-alcoholic fatty liver disease by activating AMP-activated protein kinase","volume":"29","author":"Shang","year":"2008","journal-title":"Acta Pharm. Sin."},{"issue":"3","key":"10.1016\/j.biopha.2022.113849_bib33","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1053\/j.gastro.2013.11.049","article-title":"Increased de novo lipogenesis is a distinct characteristic of individuals with nonalcoholic fatty liver disease","volume":"146","author":"Lambert","year":"2014","journal-title":"Gastroenterology"},{"key":"10.1016\/j.biopha.2022.113849_bib34","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.bcp.2018.11.020","article-title":"Targeting mitochondria to oppose the progression of nonalcoholic fatty liver disease","volume":"160","author":"Grattagliano","year":"2019","journal-title":"Biochem Pharm."},{"issue":"4","key":"10.1016\/j.biopha.2022.113849_bib35","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.tem.2016.11.006","article-title":"Mitochondrial adaptation in nonalcoholic fatty liver disease: Novel mechanisms and treatment strategies","volume":"28","author":"Sunny","year":"2017","journal-title":"Trends Endocrinol. Metab."},{"issue":"3","key":"10.1016\/j.biopha.2022.113849_bib36","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1053\/j.gastro.2018.06.083","article-title":"Mitochondrial dysfunction and signaling in chronic liver diseases","volume":"155","author":"Gattolliat","year":"2018","journal-title":"Gastroenterology"},{"issue":"1","key":"10.1016\/j.biopha.2022.113849_bib37","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.numecd.2009.06.002","article-title":"A novel component of the metabolic syndrome: the oxidative stress","volume":"20","author":"Hopps","year":"2010","journal-title":"Nutr. Metab. Cardiovasc Dis."},{"key":"10.1016\/j.biopha.2022.113849_bib38","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.jep.2015.08.032","article-title":"Hepatoprotective activity of total iridoid glycosides isolated from Paederia scandens (lour.) Merr. var. tomentosa","volume":"174","author":"Peng","year":"2015","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.biopha.2022.113849_bib39","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2020.568006","article-title":"Resveratrol attenuates high-fat diet induced hepatic lipid homeostasis disorder and decreases m(6)A RNA methylation","volume":"11","author":"Wu","year":"2020","journal-title":"Front. Pharm."},{"issue":"6","key":"10.1016\/j.biopha.2022.113849_bib40","doi-asserted-by":"crossref","first-page":"4290","DOI":"10.1111\/jcmm.14320","article-title":"The phytochemical polydatin ameliorates non-alcoholic steatohepatitis by restoring lysosomal function and autophagic flux","volume":"23","author":"Chen","year":"2019","journal-title":"J. Cell Mol. Med."},{"issue":"2","key":"10.1016\/j.biopha.2022.113849_bib41","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1007\/s11418-013-0810-z","article-title":"Antidyslipidemic effect and antioxidant activity of anthraquinone derivatives from Rheum emodi rhizomes in dyslipidemic rats","volume":"68","author":"Mishra","year":"2014","journal-title":"J. Nat. Med."},{"key":"10.1016\/j.biopha.2022.113849_bib42","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/s12986-019-0362-7","article-title":"Physcion reduces lipid accumulation and prevents the obesity in mice","volume":"16","author":"Lee","year":"2019","journal-title":"Nutr. Metab. (Lond.)"},{"issue":"4","key":"10.1016\/j.biopha.2022.113849_bib43","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1016\/j.bbrc.2016.11.101","article-title":"Luteolin improves non-alcoholic fatty liver disease in db\/db mice by inhibition of liver X receptor activation to down-regulate expression of sterol regulatory element binding protein 1c","volume":"482","author":"Yin","year":"2017","journal-title":"Biochem Biophys. Res. Commun."},{"issue":"8","key":"10.1016\/j.biopha.2022.113849_bib44","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1038\/s41401-020-0392-8","article-title":"Aloe-emodin exerts cholesterol-lowering effects by inhibiting proprotein convertase subtilisin\/kexin type 9 in hyperlipidemic rats","volume":"41","author":"Su","year":"2020","journal-title":"Acta Pharm. Sin."},{"key":"10.1016\/j.biopha.2022.113849_bib45","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.2147\/DDDT.S243893","article-title":"Radix Polygoni multiflori and its main component emodin attenuate non-alcoholic fatty liver disease in zebrafish by regulation of AMPK signaling pathway","volume":"14","author":"Yu","year":"2020","journal-title":"Drug Des. Devel Ther."},{"issue":"8","key":"10.1016\/j.biopha.2022.113849_bib46","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1177\/1535370214530247","article-title":"Emodin attenuates systemic and liver inflammation in hyperlipidemic mice administrated with lipopolysaccharides","volume":"239","author":"Jia","year":"2014","journal-title":"Exp. Biol. Med. (Maywood)"},{"issue":"5","key":"10.1016\/j.biopha.2022.113849_bib47","doi-asserted-by":"crossref","first-page":"E886","DOI":"10.1152\/ajpendo.00332.2010","article-title":"Rhein ameliorates fatty liver disease through negative energy balance, hepatic lipogenic regulation, and immunomodulation in diet-induced obese mice","volume":"300","author":"Sheng","year":"2011","journal-title":"Am. J. Physiol. Endocrinol. Metab."}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332222012380?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332222012380?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T11:56:50Z","timestamp":1778241410000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332222012380"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12]]},"references-count":47,"alternative-id":["S0753332222012380"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2022.113849","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2022,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"In vivo identification of the pharmacodynamic ingredients of Polygonum cuspidatum for remedying the mitochondria to alleviate metabolic dysfunction\u2013associated fatty liver disease","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2022.113849","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"113849"}}